KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Non-cash Items: 2009-2024

Historic Non-cash Items for Acadia Pharmaceuticals (ACAD) over the last 14 years, with Dec 2024 value amounting to $7.0 million.

  • Acadia Pharmaceuticals' Non-cash Items fell 92.31% to $7.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.0 million, marking a year-over-year decrease of 92.31%. This contributed to the annual value of $7.0 million for FY2024, which is 92.31% down from last year.
  • According to the latest figures from FY2024, Acadia Pharmaceuticals' Non-cash Items is $7.0 million, which was down 92.31% from $91.0 million recorded in FY2023.
  • In the past 5 years, Acadia Pharmaceuticals' Non-cash Items registered a high of $91.0 million during FY2023, and its lowest value of $1.1 million during FY2022.
  • Over the past 3 years, Acadia Pharmaceuticals' median Non-cash Items value was $7.0 million (recorded in 2024), while the average stood at $33.0 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Non-cash Items plummeted by 96.08% in 2020 and then soared by 8,546.58% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Non-cash Items (Yearly) stood at $9.7 million in 2020, then skyrocketed by 69.38% to $16.4 million in 2021, then slumped by 93.59% to $1.1 million in 2022, then skyrocketed by 8,546.58% to $91.0 million in 2023, then tumbled by 92.31% to $7.0 million in 2024.